Cargando…
Lipid Profile, Renal Function Tests and Inflammatory Markers in Algerian Type 2 Diabetic Patients
BACKGROUND: Several studies show the relationship between chronic hyperglycemia and the appearance of macroangiopathy, microangiopathy and neuropathy. The major objective of this study was to investigate the serum lipids, renal function tests and inflammatory markersin type 2 diabetes patients. METH...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Tehran University of Medical Sciences
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404330/ https://www.ncbi.nlm.nih.gov/pubmed/37551187 http://dx.doi.org/10.18502/ijph.v52i4.12441 |
_version_ | 1785085275058208768 |
---|---|
author | Hadjari, Mohammed Bereksi, Karima |
author_facet | Hadjari, Mohammed Bereksi, Karima |
author_sort | Hadjari, Mohammed |
collection | PubMed |
description | BACKGROUND: Several studies show the relationship between chronic hyperglycemia and the appearance of macroangiopathy, microangiopathy and neuropathy. The major objective of this study was to investigate the serum lipids, renal function tests and inflammatory markersin type 2 diabetes patients. METHODS: The study lasted eight years between Feb-2013 and Mar-2021 (Mascara, Algeria). Overall,197 patients and 197 controls were selected during general medicine examinations; enzymatic and immunoturbidimetric colorimetric methods were used to determine the serum levels offasting glycaemia, total cholesterol, highdensity lipoprotein cholesterol, triglycerides, low-density lipoprotein cholesterol, fibrinogen, urea, acid uric, albumin and creatinine, C protein reactive; the glomerular filtration rate is calculated according to the MDRD equation; the glycatedhaemoglobin levels were determined by an ion-exchange resin separation method. RESULTS: Patients had 2.44 times higher fasting glycaemia, 1.71 times higher HbA1c, 1.23 times higher body mass index, 1.30 times higher waist circumference and 1.25times higher systolic blood pressure than control subjects; the findings of the present study also indicate that a significant differences between patients and controls were observed regarding triglycerides (P=0.008), LDL-cholesterol (P=0.011), HDL-cholesterol (P=0.009), urea (P=0.013), uric acid (P=0.015), creatinine (P=0.007), glomerular filtration rate (P=0.006), albumin (P=0.018), fibrinogen (P=0.023) and C protein reactive (P=0.019). CONCLUSION: All this metabolic disordercould facilitate the appearance of serious complications in future. |
format | Online Article Text |
id | pubmed-10404330 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Tehran University of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-104043302023-08-07 Lipid Profile, Renal Function Tests and Inflammatory Markers in Algerian Type 2 Diabetic Patients Hadjari, Mohammed Bereksi, Karima Iran J Public Health Original Article BACKGROUND: Several studies show the relationship between chronic hyperglycemia and the appearance of macroangiopathy, microangiopathy and neuropathy. The major objective of this study was to investigate the serum lipids, renal function tests and inflammatory markersin type 2 diabetes patients. METHODS: The study lasted eight years between Feb-2013 and Mar-2021 (Mascara, Algeria). Overall,197 patients and 197 controls were selected during general medicine examinations; enzymatic and immunoturbidimetric colorimetric methods were used to determine the serum levels offasting glycaemia, total cholesterol, highdensity lipoprotein cholesterol, triglycerides, low-density lipoprotein cholesterol, fibrinogen, urea, acid uric, albumin and creatinine, C protein reactive; the glomerular filtration rate is calculated according to the MDRD equation; the glycatedhaemoglobin levels were determined by an ion-exchange resin separation method. RESULTS: Patients had 2.44 times higher fasting glycaemia, 1.71 times higher HbA1c, 1.23 times higher body mass index, 1.30 times higher waist circumference and 1.25times higher systolic blood pressure than control subjects; the findings of the present study also indicate that a significant differences between patients and controls were observed regarding triglycerides (P=0.008), LDL-cholesterol (P=0.011), HDL-cholesterol (P=0.009), urea (P=0.013), uric acid (P=0.015), creatinine (P=0.007), glomerular filtration rate (P=0.006), albumin (P=0.018), fibrinogen (P=0.023) and C protein reactive (P=0.019). CONCLUSION: All this metabolic disordercould facilitate the appearance of serious complications in future. Tehran University of Medical Sciences 2023-04 /pmc/articles/PMC10404330/ /pubmed/37551187 http://dx.doi.org/10.18502/ijph.v52i4.12441 Text en Copyright © 2023 Hadjari et al. Published by Tehran University of Medical Sciences. https://creativecommons.org/licenses/by-nc/4.0/This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International license (https://creativecommons.org/licenses/by-nc/4.0/). Non-commercial uses of the work are permitted, provided the original work is properly cited. |
spellingShingle | Original Article Hadjari, Mohammed Bereksi, Karima Lipid Profile, Renal Function Tests and Inflammatory Markers in Algerian Type 2 Diabetic Patients |
title | Lipid Profile, Renal Function Tests and Inflammatory Markers in Algerian Type 2 Diabetic Patients |
title_full | Lipid Profile, Renal Function Tests and Inflammatory Markers in Algerian Type 2 Diabetic Patients |
title_fullStr | Lipid Profile, Renal Function Tests and Inflammatory Markers in Algerian Type 2 Diabetic Patients |
title_full_unstemmed | Lipid Profile, Renal Function Tests and Inflammatory Markers in Algerian Type 2 Diabetic Patients |
title_short | Lipid Profile, Renal Function Tests and Inflammatory Markers in Algerian Type 2 Diabetic Patients |
title_sort | lipid profile, renal function tests and inflammatory markers in algerian type 2 diabetic patients |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10404330/ https://www.ncbi.nlm.nih.gov/pubmed/37551187 http://dx.doi.org/10.18502/ijph.v52i4.12441 |
work_keys_str_mv | AT hadjarimohammed lipidprofilerenalfunctiontestsandinflammatorymarkersinalgeriantype2diabeticpatients AT bereksikarima lipidprofilerenalfunctiontestsandinflammatorymarkersinalgeriantype2diabeticpatients |